Amy Baca, MD
Internal Medicine · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 11 years
- University of New Mexico School of Medicine, 2015
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: 057003 · Alta Bates Summit Medical Center - Alta Bates Camp · California Pacific Medical Center - Mission Bernal · California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp · Novato Community Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Baca’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$82,679
Medicare paid this office $82,679 for 155 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 134 | $43,556 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 50 | $7,768 | $155 |
| Long return visit (40+ min) | 43 | $7,296 | $138 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 21 | $6,115 | $291 |
| Sarscov2 vac 50 mcg/0.5ml im | 25 | $4,521 | $151 |
See all 11 services
| Return visit (30+ min) | 134 | $43,556 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 50 | $7,768 | $155 |
| Long return visit (40+ min) | 43 | $7,296 | $138 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 21 | $6,115 | $291 |
| Sarscov2 vac 50 mcg/0.5ml im | 25 | $4,521 | $151 |
| Influenza vaccine, inactivated | 19 | $1,555 | $82 |
| Admn sarscov2 vacc 1 dose | 25 | $1,548 | $52 |
| Short return visit (20+ min) | 16 | $1,329 | $74 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 37 | $858 | $14 |
| Administration of pneumococcal vaccine | 21 | $812 | $39 |
| Administration of influenza virus vaccine | 20 | $774 | $39 |
Who their Medicare patients are
155 Original Medicare patients in 2024. Average age 73 · Women 42% · Also on Medicaid 17% · Health risk score 1.04. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 66% · Chronic kidney disease 29% · Depression 26% · Coronary heart disease 23% · Diabetes 22% · Atrial fibrillation 15% · Cancer 12% · Heart failure 9% · COPD 9% · Dementia 8%.
The office billed $247,334, Medicare allowed $106,762 and paid $82,679; for 1,104 services of 35 kinds; $12,664 of it was for drugs given in the office and $70,015 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 155 | 1,104 | 73 | 1.04 | $247,334 | $82,679 |
| 2023 | 168 | 750 | 72 | 0.99 | $207,233 | $70,772 |
| 2022 | 150 | 518 | 72 | 0.87 | $150,900 | $50,176 |
| 2021 | 241 | 865 | 72 | 1.01 | $214,373 | $73,566 |
| 2020 | 419 | 1,136 | 71 | 1.08 | $282,428 | $78,004 |
| 2019 | 14 | 25 | 72 | 0.95 | $7,024 | $1,945 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 144 | $39,192 | $107 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 58 | $9,078 | $157 |
| Long return visit (40+ min) | 36 | $7,464 | $146 |
| Short return visit (20+ min) | 36 | $3,371 | $78 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $2,104 | $100 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 23 | $1,744 | $76 |
| Sarscov2 vac 50 mcg/0.5ml im | 12 | $1,716 | $143 |
| Administration of influenza virus vaccine | 28 | $1,040 | $37 |
| Admn sarscov2 vacc 1 dose | 12 | $594 | $50 |
2022: 7 services
| Return visit (30+ min) | 110 | $26,166 | $109 |
| Long return visit (40+ min) | 32 | $7,884 | $155 |
| Short return visit (20+ min) | 60 | $5,360 | $71 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,805 | $156 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,342 | $79 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 19 | $1,335 | $70 |
| Administration of influenza virus vaccine | 25 | $914 | $37 |
2021: 9 services
| Return visit (30+ min) | 160 | $33,992 | $102 |
| Long return visit (40+ min) | 39 | $10,117 | $156 |
| Short return visit (20+ min) | 93 | $9,739 | $73 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $5,866 | $159 |
| Influenza vaccine split virus, preservative free | 34 | $2,219 | $65 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,903 | $91 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $1,805 | $64 |
| Administration of influenza virus vaccine | 42 | $888 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $260 | $14 |
2020: 13 services
| Return visit (30+ min) | 201 | $29,280 | $82 |
| Short return visit (20+ min) | 196 | $17,675 | $58 |
| Long return visit (40+ min) | 36 | $5,236 | $114 |
| Influenza vaccine split virus, preservative free | 80 | $4,836 | $60 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $3,108 | $94 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,053 | $137 |
| Pneumococcal vaccine, 23-valent | 17 | $2,023 | $119 |
| Administration of influenza virus vaccine | 92 | $1,891 | $21 |
| Telephone medical discussion with physician, 11-20 minutes | 28 | $1,879 | $63 |
| Short return visit | 31 | $1,418 | $46 |
| Administration of pneumococcal vaccine | 25 | $512 | $20 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 13 | $255 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $245 | $16 |
Medicaid work
$4,862 in 2024
Medicaid paid $4,862 for 168 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 168 | $4,862 |
| 2024 | 168 | 1 | 24 | $4,862 |
| 2023 | 165 | 1 | 19 | $4,253 |
| 2022 | 99 | 2 | 20 | $1,006 |
| 2019 | 16 | 1 | 15 | $4,810 |
| 2018 | 49 | 2 | 19 | $8,519 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 165 | $4,253 |
2022
| Return visit (30+ min) | 86 | $826 |
| Short return visit (20+ min) | 13 | $179 |
2019
| Clinic visit/encounter, all-inclusive | 16 | $4,810 |
2018
| Clinic visit/encounter, all-inclusive | 34 | $8,519 |
| Short return visit (20+ min) | 15 | $0 |
Drugs they prescribed that Part D paid
$564,117
Pharmacies billed $564,117 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (40 of 1,970) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%. Long-acting opioids: 30% of their opioid prescriptions.
1,630 generic and fewer than 11 brand-name prescriptions · $564,117 in drug cost · 27 antibiotic prescriptions to 24 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Descovy | 38 | $104,741 | $2,756 |
| Biktarvy | 23 | $97,655 | $4,246 |
| Tivicay | 26 | $81,686 | $3,142 |
| Triumeq | 13 | $48,085 | $3,699 |
| Dovato | 12 | $40,511 | $3,376 |
See all 45 drugs
| Descovy | 38 | $104,741 | $2,756 |
| Biktarvy | 23 | $97,655 | $4,246 |
| Tivicay | 26 | $81,686 | $3,142 |
| Triumeq | 13 | $48,085 | $3,699 |
| Dovato | 12 | $40,511 | $3,376 |
| Eliquis | 15 | $20,181 | $1,345 |
| Maraviroc | 12 | $14,830 | $1,236 |
| Jardiance | 15 | $13,416 | $894 |
| Megestrol Acetate | 13 | $4,759 | $366 |
| Rosuvastatin | 110 | $2,085 | $19 |
| Valacyclovir | 34 | $1,965 | $58 |
| Atorvastatin | 126 | $1,309 | $10 |
| Amlodipine Besylate | 114 | $1,148 | $10 |
| Levothyroxine | 70 | $943 | $13 |
| Diltiazem 24hr Er (Cd) | 13 | $912 | $70 |
| Losartan | 65 | $790 | $12 |
| Escitalopram | 50 | $743 | $15 |
| Bupropion Xl | 24 | $732 | $31 |
| Lisinopril | 70 | $697 | $10 |
| Albuterol Sulfate Hfa | 26 | $689 | $27 |
| Tamsulosin | 34 | $607 | $18 |
| Trazodone | 49 | $577 | $12 |
| Gabapentin | 33 | $492 | $15 |
| Fluticasone Propionate | 17 | $435 | $26 |
| Mirtazapine | 17 | $408 | $24 |
| Omeprazole | 32 | $332 | $10 |
| Metformin | 31 | $303 | $10 |
| Morphine Sulfate Er | 12 | $300 | $25 |
| Pantoprazole | 30 | $265 | $9 |
| Metoprolol | 17 | $261 | $15 |
| Allopurinol | 22 | $256 | $12 |
| Hydrochlorothiazide | 48 | $218 | $5 |
| Oxycodone-Acetaminophen | 19 | $173 | $9 |
| Famotidine | 13 | $169 | $13 |
| Clonazepam | 22 | $160 | $7 |
| Sertraline | 14 | $147 | $10 |
| Duloxetine | 16 | $145 | $9 |
| Dicyclomine | 12 | $115 | $10 |
| Alendronate | 15 | $115 | $8 |
| Meclizine | 26 | $108 | $4 |
| Metformin Hcl Er | 12 | $101 | $8 |
| Furosemide | 32 | $79 | $2 |
| Alprazolam | 14 | $41 | $3 |
| Montelukast | 12 | $25 | $2 |
| Lorazepam | 14 | $25 | $2 |
Year by year
| 2024 | 1,970 | 184 | 2% (40) | None | $564,117 |
| 2023 | 1,923 | 187 | 2% (35) | 18% | $659,094 |
| 2022 | 1,796 | 180 | 1% (24) | 20% | $643,707 |
| 2021 | 1,256 | 136 | 4% (53) | 24% | $492,224 |
| 2020 | 695 | 94 | 7% (48) | None | $244,010 |
| 2019 | 155 | 17 | 0% (0) | None | $58,899 |
| 2018 | 48 | 13 | None | None | $12,070 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 50 drugs
| Biktarvy | 38 | $156,659 | $4,123 |
| Descovy | 38 | $103,638 | $2,727 |
| Tivicay | 34 | $76,050 | $2,237 |
| Dovato | 14 | $65,356 | $4,668 |
| Maraviroc | 11 | $13,592 | $1,236 |
| Megestrol Acetate | 12 | $4,492 | $374 |
| Rosuvastatin | 89 | $2,852 | $32 |
| Atorvastatin | 116 | $1,674 | $14 |
| Albuterol Sulfate Hfa | 34 | $1,550 | $46 |
| Valacyclovir | 22 | $1,470 | $67 |
| Amlodipine Besylate | 77 | $1,208 | $16 |
| Levothyroxine | 66 | $1,158 | $18 |
| Bupropion Xl | 22 | $1,150 | $52 |
| Trazodone | 61 | $1,116 | $18 |
| Ventolin Hfa | 17 | $1,025 | $60 |
| Tamsulosin | 39 | $947 | $24 |
| Mirtazapine | 25 | $884 | $35 |
| Lisinopril | 56 | $858 | $15 |
| Ritonavir | 13 | $792 | $61 |
| Losartan | 64 | $742 | $12 |
| Metoprolol | 23 | $580 | $25 |
| Allopurinol | 29 | $499 | $17 |
| Escitalopram | 32 | $492 | $15 |
| Famotidine | 19 | $491 | $26 |
| Omeprazole | 30 | $489 | $16 |
| Metformin | 27 | $406 | $15 |
| Fluticasone Propionate | 14 | $398 | $28 |
| Alendronate | 13 | $390 | $30 |
| Morphine Sulfate Er | 12 | $358 | $30 |
| Gabapentin | 22 | $328 | $15 |
| Oxycodone-Acetaminophen | 21 | $313 | $15 |
| Losartan-Hydrochlorothiazide | 12 | $300 | $25 |
| Pantoprazole | 17 | $277 | $16 |
| Sertraline | 19 | $257 | $14 |
| Montelukast | 16 | $246 | $15 |
| Acyclovir | 15 | $234 | $16 |
| Lamivudine | 12 | $224 | $19 |
| Finasteride | 25 | $209 | $8 |
| Hydrochlorothiazide | 36 | $208 | $6 |
| Duloxetine | 16 | $201 | $13 |
| Doxycycline Monohydrate | 11 | $199 | $18 |
| Sumatriptan | 11 | $171 | $16 |
| Alprazolam | 21 | $113 | $5 |
| Ibuprofen | 11 | $103 | $9 |
| Potassium Chloride | 11 | $100 | $9 |
| Zolpidem | 13 | $86 | $7 |
| Pravastatin | 12 | $75 | $6 |
| Lorazepam | 22 | $62 | $3 |
| Furosemide | 26 | $61 | $2 |
| Clonazepam | 20 | $47 | $2 |
2022: 47 drugs
| Biktarvy | 58 | $227,736 | $3,926 |
| Descovy | 28 | $74,789 | $2,671 |
| Tivicay | 32 | $67,264 | $2,102 |
| Dovato | 14 | $51,677 | $3,691 |
| Selzentry | 12 | $20,709 | $1,726 |
| Januvia | 11 | $16,406 | $1,491 |
| Xarelto | 13 | $6,396 | $492 |
| Rosuvastatin | 42 | $2,095 | $50 |
| Mirtazapine | 36 | $1,702 | $47 |
| Albuterol Sulfate Hfa | 26 | $1,530 | $59 |
| Levothyroxine | 72 | $1,486 | $21 |
| Ezetimibe | 12 | $1,375 | $115 |
| Atorvastatin | 103 | $1,218 | $12 |
| Bupropion Xl | 15 | $1,104 | $74 |
| Valacyclovir | 19 | $1,103 | $58 |
| Doxycycline Monohydrate | 14 | $1,013 | $72 |
| Trazodone | 58 | $685 | $12 |
| Metoprolol | 32 | $649 | $20 |
| Losartan | 45 | $588 | $13 |
| Escitalopram | 37 | $586 | $16 |
| Montelukast | 26 | $483 | $19 |
| Amlodipine Besylate | 80 | $474 | $6 |
| Lisinopril | 61 | $411 | $7 |
| Omeprazole | 21 | $388 | $18 |
| Famotidine | 18 | $368 | $20 |
| Hydrocortisone | 15 | $365 | $24 |
| Tamsulosin | 18 | $354 | $20 |
| Pantoprazole | 22 | $330 | $15 |
| Venlafaxine Hcl Er | 16 | $327 | $20 |
| Acyclovir | 16 | $283 | $18 |
| Diltiazem 24hr Er (Xr) | 12 | $277 | $23 |
| Duloxetine | 15 | $250 | $17 |
| Metformin | 33 | $247 | $7 |
| Allopurinol | 20 | $246 | $12 |
| Sertraline | 19 | $225 | $12 |
| Simvastatin | 19 | $224 | $12 |
| Oxycodone-Acetaminophen | 13 | $181 | $14 |
| Baclofen | 11 | $168 | $15 |
| Hydrochlorothiazide | 31 | $145 | $5 |
| Calcitriol | 11 | $122 | $11 |
| Alprazolam | 17 | $104 | $6 |
| Finasteride | 14 | $78 | $6 |
| Clonazepam | 31 | $73 | $2 |
| Pravastatin | 13 | $61 | $5 |
| Lorazepam | 16 | $53 | $3 |
| Furosemide | 13 | $49 | $4 |
| Gabapentin | 11 | $40 | $4 |
2021: 33 drugs
| Biktarvy | 36 | $129,057 | $3,585 |
| Tivicay | 44 | $109,071 | $2,479 |
| Descovy | 30 | $61,177 | $2,039 |
| Pifeltro | 16 | $26,245 | $1,640 |
| Xarelto | 11 | $5,725 | $520 |
| Wixela Inhub | 13 | $4,409 | $339 |
| Fluticasone-Salmeterol | 11 | $2,818 | $256 |
| Albuterol Sulfate Hfa | 32 | $2,108 | $66 |
| Bupropion Xl | 18 | $1,780 | $99 |
| Mirtazapine | 37 | $1,184 | $32 |
| Atorvastatin | 66 | $963 | $15 |
| Levothyroxine | 41 | $912 | $22 |
| Oxycodone-Acetaminophen | 13 | $586 | $45 |
| Famotidine | 19 | $537 | $28 |
| Metoprolol | 21 | $425 | $20 |
| Omeprazole | 19 | $373 | $20 |
| Duloxetine | 13 | $340 | $26 |
| Amlodipine Besylate | 54 | $334 | $6 |
| Trazodone | 32 | $334 | $10 |
| Lisinopril | 39 | $314 | $8 |
| Montelukast | 11 | $302 | $27 |
| Losartan | 26 | $287 | $11 |
| Morphine Sulfate Er | 13 | $248 | $19 |
| Escitalopram | 14 | $237 | $17 |
| Hydrochlorothiazide | 23 | $235 | $10 |
| Sertraline | 11 | $202 | $18 |
| Simvastatin | 19 | $190 | $10 |
| Alprazolam | 12 | $108 | $9 |
| Metformin | 18 | $85 | $5 |
| Glimepiride | 13 | $66 | $5 |
| Lorazepam | 13 | $41 | $3 |
| Clonazepam | 14 | $28 | $2 |
| Alcohol Prep Pads | 12 | $22 | $2 |
2020: 22 drugs
| Tivicay | 22 | $46,301 | $2,105 |
| Prezcobix | 12 | $35,551 | $2,963 |
| Pifeltro | 13 | $19,121 | $1,471 |
| Spiriva Respimat | 11 | $7,060 | $642 |
| Bupropion Xl | 18 | $2,609 | $145 |
| Diclofenac | 13 | $1,012 | $78 |
| Ventolin Hfa | 14 | $810 | $58 |
| Levothyroxine | 25 | $567 | $23 |
| Albuterol Sulfate Hfa | 12 | $542 | $45 |
| Atorvastatin | 40 | $399 | $10 |
| Morphine Sulfate Er | 11 | $336 | $31 |
| Duloxetine | 11 | $315 | $29 |
| Oxycodone-Acetaminophen | 13 | $294 | $23 |
| Mirtazapine | 16 | $209 | $13 |
| Omeprazole | 14 | $182 | $13 |
| Amlodipine Besylate | 35 | $182 | $5 |
| Trazodone | 17 | $173 | $10 |
| Ketoconazole | 11 | $155 | $14 |
| Lisinopril | 18 | $129 | $7 |
| Hydrochlorothiazide | 18 | $120 | $7 |
| Escitalopram | 12 | $110 | $9 |
| Tramadol | 12 | $80 | $7 |
2019: 2 drugs
| Metformin Hcl Er | 22 | $227 | $10 |
| Hydrochlorothiazide | 11 | $32 | $3 |
Money from drug and device companies
$17 in 2025
| 2025 | 1 | 1 | None | $17 |
| 2024 | 1 | 8 | $5,200 | $5,780 |
| 2023 | 1 | 7 | None | $421 |
| 2022 | 1 | 1 | None | $16 |
| 2021 | 1 | 1 | $2,760 | $2,760 |
| 2020 | 3 | 9 | $3,680 | $3,758 |
| 2019 | 2 | 5 | None | $76 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Paxlovid | $17 | 1 payment
|
See the published payment
| Pfizer | Meals · 2025-05-02 | Paxlovid | $17 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $5,780
| ViiV Healthcare | Cabenuva | $5,780 | 8 payments
|
2023: $421
| ViiV Healthcare | Rukobia | $421 | 7 payments
|
2022: $16
| ViiV Healthcare | Dovato | $16 | 1 payment
|
2021: $2,760
| ViiV Healthcare | Dovato | $2,760 | 1 payment
|
2020: $3,758
| ViiV Healthcare | Dovato | $3,724 | 7 payments
|
| GlaxoSmithKline | Shingrix | $22 | 1 payment
|
| Aytu Bioscience | Aciphex | $12 | 1 payment
|
2019: $76
| ViiV Healthcare | Dovato | $62 | 4 payments
|
| Gilead Sciences | None | $15 | 1 payment
|
Professional record
- NPI
- 1912393224
- Licence
- CA 1165025
- Trained
- University of New Mexico School of Medicine, 2015 · 11 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2015-04-13
- NPI last updated
- 2023-03-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 899 Valencia St, San Francisco, CA, 94110